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Abstract
Many bacterial pathogens produce extracellular proteases that degrade the extracellular matrix of the host and therefore
are involved in disease pathogenesis. Dichelobacter nodosus is the causative agent of ovine footrot, a highly contagious
disease that is characterized by the separation of the hoof from the underlying tissue. D. nodosus secretes three subtilisin-
like proteases whose analysis forms the basis of diagnostic tests that differentiate between virulent and benign strains and
have been postulated to play a role in virulence. We have constructed protease mutants of D. nodosus; their analysis in a
sheep virulence model revealed that one of these enzymes, AprV2, was required for virulence. These studies challenge the
previous hypothesis that the elastase activity of AprV2 is important for disease progression, since aprV2 mutants were
virulent when complemented with aprB2, which encodes a variant that has impaired elastase activity. We have determined
the crystal structures of both AprV2 and AprB2 and characterized the biological activity of these enzymes. These data reveal
that an unusual extended disulphide-tethered loop functions as an exosite, mediating effective enzyme-substrate
interactions. The disulphide bond and Tyr92, which was located at the exposed end of the loop, were functionally
important. Bioinformatic analyses suggested that other pathogenic bacteria may have proteases that utilize a similar
mechanism. In conclusion, we have used an integrated multidisciplinary combination of bacterial genetics, whole animal
virulence trials in the original host, biochemical studies, and comprehensive analysis of crystal structures to provide the first
definitive evidence that the extracellular secreted proteases produced by D. nodosus are required for virulence and to
elucidate the molecular mechanism by which these proteases bind to their natural substrates. We postulate that this exosite
mechanism may be used by proteases produced by other bacterial pathogens of both humans and animals.
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Introduction
Dichelobacter nodosus is a Gram negative, anaerobic rod that is the
principal causative agent of ovine footrot, a debilitating disease of
the hoof of ruminants. The disease results in significant costs to the
worldwide sheep industry due to a reduction in meat and wool
production and the expenditure associated with prevention and
treatment programs [1,2,3]. Footrot is characterized by the
separation of the keratinous hoof from the underlying tissue,
resulting in severe lameness and loss of body condition [4,5]. The
severity of the disease can vary from benign footrot, which presents
as an interdigital dermatitis that does not progress, to virulent
footrot, which results in severe under-running of the horn of the
hoof and the separation of the hoof from the underlying tissue [1].
Type IV fimbriae are an essential virulence factor [6,7]; it also has
been suggested that three closely-related secreted subtilisin-like
proteases produced by D. nodosus may be required for virulence
[8,9]. In strains that cause virulent footrot these proteases are
called acidic protease isoenzymes 2 and 5 from virulent strains
(AprV2 and AprV5) and basic protease from virulent strains
(BprV). In benign strains the comparable proteases are termed
AprB2, AprB5 and BprB. All of these proteases are synthesised as
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protease domain and a C-terminal domain of unknown function.
The active protease is produced by cleavage of the N-terminal pre-
pro region and the C-terminal domain [10,11,12]. The protease
domains have significant sequence identity to members of the
subtilase family of serine proteases (54% identity with closest
homologue from Dehalococcoides sp. VS), but sequence alignments
indicate several insertions in the D. nodosus proteases [13].
Previous studies suggested that these proteases may represent the
key difference between virulent and benign strains of D. nodosus;
proteases secreted by virulent isolates have a greater thermostability
and elastase activity (as monitored on elastin agar plates) than those
ofbenignstrainsanditispostulatedthatthisdifferencemayrelateto
their in vivo activity against host tissue. These features are utilized in
diagnostic tests to distinguish between virulent and benign footrot
[14,15,16]. Comparison of the protease sequences from the virulent
strain A198 with the benign strain C305 revealed that within the
mature protease domain there is a single amino acid difference
between AprV2 and AprB2 [12], and between AprV5 and AprB5
[11], and 96% sequence identity between BprV and BprB [17].
In this multidisciplinary study we set out to determine the role of
these proteases in virulence and to determine the molecular basis
for their function. We constructed isogenic protease mutants and
characterized their protease activity and virulence. We showed
that AprV2 was required for a virulent D. nodosus isolate to cause
disease. Determination of the crystal structure of AprV2 revealed
the presence of a novel exosite loop. This combined genetic and
structural approach has permitted a comprehensive investigation
of the secreted protease component of a pathogenic organism, and
furthermore provided novel insight into how subtilisin-like
proteases may have been hijacked by pathogenic microorganisms
to degrade extracellular matrix components.
Results
Protease activity of D. nodosus
To assess the contribution of each of the three extracellular
proteases to the overall protease activity of the virulent D. nodosus
isolate VCS1703A, separate chromosomal mutants of each
protease gene were constructed by allelic exchange events that
involved double crossovers. To confirm that the observed
phenotypes resulted from these mutations, the mutants were
complemented by insertion of the wild-type protease genes into the
chromosome. Quantitative protease assays of culture supernatants,
using azocasein as the substrate, showed that mutation of the aprV5
and aprV2 genes reduced total protease activity by 71% and 39%,
respectively (Figure 1A). Complementation with the respective
wild-type genes returned total protease activity to wild-type levels;
however, it was also observed that the complemented aprV5 strain
tended to lose protease activity upon repeated subculture. Since
only a 12% reduction (P,0.05) was observed in the bprV mutant,
BprV does not appear to make a major contribution to total
protease activity. These results indicate that AprV5, either directly
or indirectly, makes the major contribution to total extracellular
protease activity.
Figure 1. Protease activity of D. nodosus wild-type and
protease mutants. Total protease activity of 40 h culture superna-
tants was measured using azocasein as the substrate. The protease
activity is expressed relative to the wild-type activity. Means and
standard error of the mean (s.e.m.) are shown. (A) Total protease
activity of the protease mutants and their complemented derivatives.
Each of the mutants had significantly reduced (P,0.05, n=3, t-test)
protease activity compared to the wild-type strain VCS1703A, while the
complemented strains, except for the bprV complemented strain, were
not significantly different to wild-type. WT: Wild-type VCS1703A,
Benign: the benign isolate CS101. (B) Total protease activity of double
and triple protease mutants. WT: Wild-type VCS1703A, Triple: the aprV2
aprV5 bprV triple mutant. The designation (1) and (2) represents
independently derived mutants. Other genotypes are as indicated. The
protease activity of each of these mutants was significantly different to
wild-type (P,0.05, n=3, t-test).
doi:10.1371/journal.ppat.1001210.g001
Author Summary
Extracellular proteases are produced by many bacterial
pathogens and are commonly involved in the degradation
of the host extracellular matrix, facilitating invasion and
colonization. One such pathogen is Dichelobacter nodosus,
the causative agent of ovine footrot, a disease of major
economic significance to the international sheep industry.
D. nodosus secretes a number of serine proteases, which
are thought to cause the tissue damage associated with
virulent footrot. Our study showed that a D. nodosus
mutant lacking one of the three secreted proteases, AprV2,
failed to cause virulent disease in sheep. We used x-ray
crystallography to solve the structure of AprV2 and the
closely related protease AprB2. Our structures revealed an
unusual extended disulphide-tethered loop that is located
next to, but does not form part of, the primary substrate
binding site. Through targeted mutagenesis studies we
were able to show that this loop functions as an exosite,
mediating effective enzyme-substrate interactions. Bioin-
formatic analyses suggest that subtilases from other
pathogenic bacteria may contain this loop and may
therefore utilize a similar mechanism. Our multidisciplinary
research approach has provided a comprehensive under-
standing of the functional role of extracellular proteases in
the pathogenesis of ovine footrot.
Novel Exosite Loop in Subtilisin Protease
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the overall protease activity of VCS1703A, double and triple
mutants were also constructed. Only very low levels of protease
activity were observed in the aprV2bprV and aprV5bprV double
mutants (Figure 1B). Negligible protease activity was detected in
the triple mutant and the aprV2aprV5 double mutant. The
reduction in total protease activity for the double mutants was
greater than the combined reduction in the total protease activity
for the single mutants suggesting that the secreted proteases either
act synergistically to degrade target substrates or that one or more
of the proteases may be involved in the activation of the other
proteases, or both.
The ability of D. nodosus to digest insoluble elastin in an agar
medium has been used as a diagnostic test to distinguish virulent
and benign strains. Virulent isolates digest elastin within seven to
ten days, while benign strains show no digestion after .21 days
incubation [14]. Analysis of the wild type, the protease mutants
and the complemented strains on elastin agar showed that the
aprV2 mutant was unable to digest elastin, even after 30 days
incubation, whereas both the aprV5 and bprV mutants were able to
digest elastin at wild-type levels, showing clearing after 10 days
(Figure S1A). Complementation of the aprV2 mutation restored the
ability to digest elastin. In addition, the aprV5bprV mutants still had
elastase activity. These results provided evidence that the AprV2
protease was responsible for the elastase activity. Note that the
levels of elastase activity in culture supernatants were not high
enough for detection in quantitative elastase assays.
Sequence analysis of the aprV2 and aprB2 genes has shown there
is only one amino acid difference (Y92R) between the two mature
proteases [12]. To see what effect complementing the aprV2
mutant with the aprB2 gene would have on the protease phenotype
of the resultant strain we inserted the aprB2 gene from the benign
strain CS101 into the site of the disrupted aprV2 gene. Analysis of
this strain in the azocasein assay showed that its total protease
activity was not significantly different to the wild type (Figure 1A).
However, this complemented strain had the in vitro phenotype of a
benign strain since it had no elastase activity (Figure S1A), and its
protease thermostability profile (Figure S1B) was that expected of a
benign isolate [16].
The apparent difference in elastase activity between AprV2 and
AprB2 was assessed in vitro using an Elastin-Congo Red substrate
and purified recombinant proteins. Under these conditions, the
ability of AprB2 to degrade the substrate was significantly less than
AprV2 (p,0.05, Figure 2). Both proteases displayed similar
activity against the soluble chromogenic elastase substrate, N-
Methoxysuccinyl-Ala-Ala-Pro-Val p-nitroanilide (AAPVn), with
kinetic parameters that were of the same order of magnitude
(Table 1). These results suggest that the Y92R substitution does
not contribute directly to catalysis at the active site of the enzyme.
AprV2 is essential for virulence in sheep
To determine the role in disease of each of the proteases,
virulence testing in sheep was carried out on the wild type, the
aprV2, aprV5 and bprV mutants and their corresponding comple-
mented strains, using our standard procedure [6,7]. These
experiments represented a rigorous test of the ability of these
bacteria to cause disease since such pen-based trials often magnify
the ability of less virulent isolates to cause disease. Comparative
analysis of the footrot scores of sheep infected with the wild-type
strain and the aprV2 mutant revealed a significant difference
(P,0.0001); the aprV2 mutant was effectively avirulent (Figure 3).
Complementation of the aprV2 mutant with the wild-type aprV2
gene restored the wild-type virulence profile, fulfilling molecular
Koch’s postulates. To our surprise, complementation of the aprV2
mutant with aprB2 also restored a virulent phenotype, indicating
that AprV2-mediated elastase activity was not required for
virulence. Analysis of isolates obtained from infected lesions
confirmed that they had the expected phenotypic and genotypic
properties.
The aprV5 and bprV mutants were also avirulent (Figure 3), but
complementation of these strains with the respective wild-type
genes did not restore virulence, which was unexpected. Extensive
sequencing of each of the protease genes in these strains showed
them to be intact. However, upon subculture, protease secretion
and/or elastin digestion by the aprV5 and bprV complemented
strains were variable, as was their ability to undergo twitching
motility, a property that is essential for virulence [7]. Therefore,
we suggest that the complemented derivatives were genetically
unstable and that secondary mutations were being selected in these
strains. Consequently, no meaningful conclusions can be drawn
from the aprV5 and bprV sheep virulence experiments.
Figure 2. Elastase activity of AprV2, AprB2 and mutants. For
quantitative measurement of elastase activity of recombinant AprV2,
AprB2 (AprV2.Y92R) and protease mutants, purified protease was
incubated with Elastin-Congo Red at 25uC for 19 h. Elastin degradation
was detected spectroscopically at 490 nm. The mean and s.e.m are
shown (* p,0.001, n=3, one-way ANOVA compared to AprV2).
doi:10.1371/journal.ppat.1001210.g002
Table 1. Activity of AprV2, AprB2 and mutants against the
elastin like peptide AAPV(n).
Proteases Vmax (mM.s
21) KM (mM) kcat (s
21)
kcat/KM
(M
21s
21)
AprV2 0.02560.001 0.5460.15 0.02560.001 46.3
AprB2 0.03360.001 0.4160.08 0.03360.001 80.5
AprV2.C141S 0.02060.001 0.8260.24 0.02060.001 24.4
AprV2.Y92F 0.03460.002 1.1260.18 0.03460.002 30.4
AprV2.Y92L 0.04560.001 0.9560.12 0.04560.001 47.4
AprV2.Y92A 0.03860.001 0.8360.08 0.03860.001 45.8
AprV2.Y92D 0.04160.001 0.8160.08 0.04160.001 50.6
C141S is a substitution derivative of AprV2 in which one disulphide bond has
been removed. AprB2 is equivalent to AprV2.Y92R. Experiments were
conducted at 25uC using 1 mM purified protease.
doi:10.1371/journal.ppat.1001210.t001
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Since the elastase activity of AprV2 was not required for
virulence it was of interest to determine which hoof proteins were
degraded by Aprv2 and AprB2. Fragments of hoof from a disease-
free sheep were exposed to recombinant AprV2 and AprB2 and
solubilised proteins were identified. AprV2 degraded type I
keratin, serum albumin and the beta subunit of haemoglobin
(Figure 4). Importantly, the hoof digestion pattern produced by
AprB2 was similar to that produced by AprV2 (Figure 4), which is
consistent with results of the virulence trials.
AprV2 contains a novel disulfide tethered extended loop
To investigate how the single amino acid difference (Y92R)
between the active forms of AprV2 and AprB2 alters the substrate
specificity of AprB2 we determined the crystal structures of AprV2
and AprB2 to 2.0 A ˚ and 1.7 A ˚, respectively (Table 2; Figure 5A,B).
The two structures were very similar (RMSD of 0.28 A ˚ for 339 Ca)
(Figure 5C) and therefore we will describe the structure with
reference to AprV2.
AprV2 adopts a subtilisin-like fold consisting of a curved six-
stranded parallel beta sheet sandwiched between two and five
alpha helices (Figure 5A, B). A two stranded anti-parallel beta
hairpin runs perpendicular to the plane of the central beta sheet.
The proteases have two disulphide bonds, Cys89-Cys141 and
Cys183-Cys220 and three calcium binding sites (Figure S2). The
proposed catalytic triad (Asp41, His105 and Ser277) of AprV2 is
located at the C-terminal edge of the beta sheet. The most striking
feature of the substrate binding site is a large, elongated S1 binding
pocket, which is lined by residues 177–180, 204–208, 215 and 218,
and appears capable of accommodating bulky side-chains such as
phenylalanine (Figure 5D). This finding is consistent with previous
studies, which have shown that AprV2 preferentially cleaves after
phenylalanine or leucine residues [18].
Comparison with other subtilisin-like proteases reveals several
major insertions (termed I1-I4) in the loops that surround the
active site cleft (Figure 6A, B; Figure S3). Most notable is the large
well ordered I2 loop (residues 82–102) that is tethered to the
subtilisin-like fold by a disulphide bond between Cys141 and
Cys89 (Figure 6). The loop is well defined in the electron density,
with low B-factors, suggesting that it has limited mobility in the
crystal structure (Figure 6C). However, the apparent stability of
Figure 4. Degradation of sheep hoof by recombinant protease.
The activity of AprV2, AprB2 and AprV2.C141S on fragments of hoof
isolated from a disease free sheep. C141S is a substitution derivative of
AprV2 in which one disulphide bond has been removed. The
degradation products were visualised by SDS-PAGE. Degraded proteins
were identified by in-gel tryptic digest followed by LCMS. I: intact
proteins; D: degraded proteins; NP: no protease added.
doi:10.1371/journal.ppat.1001210.g004
Figure 3. Virulence testing of isogenic isolates in sheep. Sheep
were challenged with the wild type, the three protease mutants and
their complemented derivatives in a blind pen trial. The total weighted
foot score (TWFS) for individual sheep at week three is shown. The
mean and the s.e.m. for each group are shown. Each mutant is
significantly different to the wild-type, while the aprV2/aprV2
+ and
aprV2/aprB2
+ complemented strains are not significantly different to
wild-type (P,0.05, n=8, one-way ANOVA). NC: negative control, not
infected with bacteria.
doi:10.1371/journal.ppat.1001210.g003
Table 2. Structure refinement statistics for AprV2, AprB2 and
AprV2.C141S.
AprV2 AprB2 AprV2.C141S
Resolution (A ˚) 24.3–2.0 20.4–1.7 24.1–2.1
No. reflections 16,749 25,598 14,360
Rwork/Rfree
a 17.7/23.3 13.8/17.8 18.2/23.7
No. atoms
Protein 2495 2498 2468
Ligand/ion (Ca
2+)3 3 3
Water 155 371 81
B-factors
Protein 14.9 12.4 17.2
Ligand/ion (Ca
2+) 21.8 11.0 33.2
Water 17.8 26.3 17.9
r.m.s. deviations
Bond lengths (A ˚) 0.012 0.011 0.011
Bond angles (u) 1.343 1.229 1.229
Ramachandran plot (%)
Favoured region 96.2 96.7 95.3
Allowed region 3.8 3.3 4.4
Disallowed region 0 0 0.3
MOLPROBITY score 1.85 1.51 1.75
aR=g |Fobs 2 Fcal|/gFobs, where Rfree is calculated with the 5% of data omitted
from the refinement and Rcryst with the remaining 95% of the data included in
the refinement.
r.m.s.: root-mean-square.
doi:10.1371/journal.ppat.1001210.t002
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if this conformation would be favoured in solution. Surprisingly,
the single amino acid difference between AprV2 and AprB2
(Y92R) is located at the tip of this extended loop, ,27 A ˚ from the
active site serine (S277). A PSI-BLAST search revealed that the
additional loops present in AprV2 may be conserved in other
extracellular proteases (Figure S3B).
We constructed an I2 loop truncation mutant, AprV2D83–99,
but the resultant protein was not functional, therefore we
investigated the role of the I2 loop using site-directed mutagenesis.
We targeted residue 92 as the Y92R substitution reduced the
ability of AprB2 to degrade Elastin-Congo Red (Figure 2), while
maintaining its ability to degrade the elastin-like peptide AAPVn
(Table 1). We used site-directed mutagenesis to convert Tyr92 to
Asp, Ala, Leu or Phe and examined the ability of the resultant
proteins to degrade insoluble Elastin-Congo Red. While the
presence of a negative charge (Asp), positive charge (Arg) or
smaller hydrophobic (Ala and Leu) side-chain decreased elastin
degradation, the Phe substitution increased the elastase activity of
the enzyme (Figure 2). We also examined the ability of these
mutants to degrade AAPVn (Table 1), fibronectin (Figure S4) or
hoof material (Figure S5). No major differences were discernable.
Based on these data we conclude that an aromatic ring is required
at position 92 for maximal activity against insoluble elastin, but
Figure 5. Crystal structure of AprV2. (A) and (B) Cartoon representation of AprV2. Two views differing by 90u are shown. Disulphide bonds are
shown in yellow stick representation. Calcium ions found in the crystal structure are shown as pink spheres. (C) An overlay of the crystal structures of
AprV2 (blue) and AprB2 (yellow). The structures are shown as a Ca trace. The I2 loop is labelled. Tyr 92 in AprV2 and Arg 92 in AprB2 are shown in stick
representation and labelled. (D) Electrostatic potential surface of AprV2 generated using CCP4mg [50]. Positively charged electrostatic potential is
coloured blue and negatively charged electrostatic potential is coloured red. The location of the active site residues is indicated. The location of the
S1 binding pocket is indicated. (A), (B) and (C) were prepared using PyMol [51]. The structural alignment in (C) was prepared using MUSTANG [52].
Secondary structure elements were calculated using stride [53].
doi:10.1371/journal.ppat.1001210.g005
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footrot lesion.
The Cys89-Cys141 disulphide bond is required for
optimal activity
To test the importance of the Cys89-Cys141 disulfide bond for
proteolytic activity, we also used site-directed mutagenesis to
convert Cys141 to Ser141. Although this AprV2.C141S derivative
was still active against small peptide substrates (Table 1), we noted
that the ability of this enzyme to degrade fibronectin, insoluble
elastin and proteins from sheep hoof was reduced. Notably, wild-
type AprV2 was able to break down fibronectin in 48 h, whereas
at the corresponding time point AprV2.C141S-treated fibronectin
was still intact (Figure 7A). The elastinolytic activity of the C141S
protease was also approximately two-fold lower than wild type
(Figure 2). Finally, the ability of AprV2.C141S to degrade sheep
hoof material was significantly reduced compared to AprV2 and
AprB2 (Figure 4). Together these data suggest that the integrity of
the I2 loop and the Cys89-Cys141 disulfide bond is important for
maximal AprV2 protease activity.
To determine whether the C141S substitution affects the
conformation/mobility of the I2 loop we determined the crystal
structure of AprV2.C141S to 2.1 A ˚ (structure refinement statistics
in Table 2). The structure of AprV2.C141S was very similar to
that of AprV2, overlaying with an RMSD of 0.21 A ˚ for 339 Ca.
The structure confirmed the absence of the Cys89-Cys141
disulfide bond and revealed that while the I2 loop had a slightly
different structure to that of AprV2 there were no significant
differences in the structure of the active site or primary substrate
binding site (Figure 8A and S6). The average B factors for the I2
loops in AprV2 and AprV2.C141S were 14.6 A ˚ 2 and 28.4 A ˚ 2,
respectively, indicating that the I2 loop is more mobile in the
substituted protease (Figure 8B,C). Given that the conformation of
the I2 loop is stabilized by crystal packing in all three structures we
investigated whether the I2 loop was more mobile in solution in
AprV2.C141S using intrinsic tryptophan fluorescence spectrosco-
py; the I2 loop contains two tryptophans. Steady state fluorescence
quenching data showed that the wild-type protease was more
protected from quenching by potassium iodide than the C141S
enzyme (Figure 7B), confirming that the conformation of the I2
loop in AprV2.C141S is different to that in the wild type.
Discussion
Although the extracellular proteases of D. nodosus have been
considered for many years to be potential virulence factors [9],
their importance in the pathogenesis of disease had not been
established. The analysis of their role in disease has always been
complicated by the fact each isolate produces three very closely
related proteases. The genetic approach utilized here has now
provided clear evidence that the AprV2 protease is essential for
virulence. This conclusion is based on data that showed that an
Figure 6. AprV2 contains a novel disulfide tethered loop. (A) Overlay of the crystal structures of AkP (magenta; 1DBI), thermitase (green;
1THM), Carlsburg subtilisn (yellow; 1AF4), BPN’ (orange; 1SUP) and savinase (blue; 1SVN). (B) Overlay of the crystal structures of AprV2 (red) with AkP,
thermitase, Carlsburg subtilisn, BPN’ and savinase (coloured as in (a)). The structures were superimposed using the A chains only and are shown as a
Ca trace. The I1, I2, I3 and I4 loops are labelled. Tyr 92 in AprV2 and Arg 92 are shown in stick representation and labelled. (C) Stereo view of a
2|Fo|2|Fc| electron density map depicting the disulfide tethered I2 loop of the AprV2 protease. The map is contoured at 1.2 s. Water molecules have
been removed for clarity. The conformation of this loop (cyan) is stabilised by inter and intramolecular contacts with molecules generated by
symmetry coloured blue. The alignments in (A) and (B) were generated using MUSTANG [52]. Secondary structure elements were calculated using
stride [53]. The figure was prepared using PyMol [51].
doi:10.1371/journal.ppat.1001210.g006
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isogenic wild-type strain, and that the ability to cause disease was
restored to wild-type levels in the complemented derivative. No
definitive conclusions could be drawn from the virulence testing of
the aprV5 and bprV mutants. However, it is likely that the AprV5
and BprV proteases also play a role in disease, especially since the
three secreted proteases appear to act synergistically, with the
double protease mutants, aprV2aprV5, aprV2bprV, and aprV5bprV,
showing lower secreted protease activity than that expected based
on the secreted protease activity of the individual mutants
Figure 7. Characterisation of AprV2.C141S derivative. (A) Degradation of fibronectin by purified AprV2 and AprV2.C141S at 25uC. The
degradation of fibronectin over time was assessed by SDS-PAGE analysis. (B) Stern-Volmer plot for iodide quenching of tryptophan in AprV2 and
AprV2.C141S. Purified protease was incubated with increasing amounts of KI, and the fluorescence emission intensity was recorded. The lines
represent a least squares fit of the experimental data as described previously [49]. The mean and s.e.m from three independent experiments are
shown. Note that in these figures AprV2.C141S is shown as C141S.
doi:10.1371/journal.ppat.1001210.g007
Figure 8. Crystal structure of AprV2.C141S. (A) Overlay of AprV2 (orange) with AprV2.C141S (cyan) shown in stereo. The structures are shown as
aC a trace. (B) and (C) Ribbon representation of AprV2.C141S (B) and AprV2 (C) coloured and sized according to B-factor. High B-factors are coloured
red and shown as thicker ribbon. Low B-factors are coloured blue and shown as thinner ribbon. The alignment was generated using the program
MUSTANG [52]. The figure was prepared using Pymol [51].
doi:10.1371/journal.ppat.1001210.g008
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although it could occur at the processing, secretion or substrate
level.
Benign and virulent strains of D. nodosus can be differentiated by
phenotypic analysis of their extracellular proteases, including
analysis of their elastase activity and thermostability [14,16,19,20].
We now have established that AprV2 is responsible for the elastase
activity of the virulent isolate VCS1703A. Purified AprB2, which
differs in sequence from AprV2 only at residue 92, is less efficient
at degrading elastin. Therefore, it was important to examine the
effect on virulence of complementing the aprV2 mutant with aprB2.
This AprV2
2AprB2
+ strain was benign by the standard laboratory
tests used to differentiate virulent and benign strains. Unexpect-
edly, it was virulent in the sheep footrot trial, producing disease
that was indistinguishable in footrot severity from that caused by
the isogenic wild-type strain. Since this strain still produces both
AprV5 and BprV we conclude that the presence of one benign
protease (AprB2) in combination with two virulent proteases
(AprV5 and BprV) is not sufficient to make a strain benign even
though in a laboratory diagnostic context the strain would be
designated as benign. Therefore, although it appears that the
properties of AprV2 and AprB2 are responsible for the
differentiation of benign and virulent strains in laboratory tests,
there clearly are other virulence factors, such as the other virulent
proteases, that contribute to virulent disease.
We have shown that AprV2 mediates the degradation of keratin
(Figure 4), a component of the ovine hoof that confers physical
protection and tissue integrity. This finding suggests that AprV2
has a direct role in destroying the keratin layer of the ovine hoof, a
characteristic feature of virulent footrot. The initial site of D.
nodosus attachment during infection is at the epidermal layer of the
interdigital skin and degradation of keratin in this area by AprV2
is likely to be required to break through the skin horn junction,
allowing the subsequent under-running of the horn by D. nodosus.
An intriguing feature identified in the structures of AprV2 and
AprB2 is the disulphide-tethered I2 loop. This loop is located next
to, and partially occludes, the substrate binding site of the enzyme
(Figure 6). The single amino acid difference between AprV2 and
AprB2 is located at the tip of the loop. We have shown that residue
92 is a key determinant of elastase activity. Although, substitution
of Tyr92 with Arg reduced the degradation of insoluble elastin, no
significant differences in either KM or Vmax were observed for
hydrolysis of the elastin-like peptide, AAPVn. This result suggests
that residue 92 does not contribute to catalysis at the active site of
the enzyme. Instead, the reduced elastinolytic activity of AprB2 is
likely to arise from impaired enzyme-substrate interactions at a site
distal to the active site. We therefore propose that the I2 loop
functions as an exosite, mediating the formation of a stable
enzyme-substrate complex. The disulphide bond tethering the I2
loop appears to be important for this function since its disruption
alters the mobility of the loop, which significantly reduces the
ability of the protease to degrade fibronectin, insoluble elastin and
other proteins from the sheep hoof.
We have identified several serine proteases that like AprV2 also
appear to contain large insertions between the b1 strand and a2
helix (the location of the I1 and I2 loops) (Figure S3). These
enzymes include MprA, from Burkholderia pseudomallei (the causative
agent of melioidosis), TgSUB1 and TgSUB2, from Toxoplasma
gondii (the causative agent of toxoplasmosis) and PfSUB1 from the
malaria parasite Plasmodium falciparum. MprA degrades physiolog-
ically relevant proteins and may play a role in causing the lung
damage associated with melioidosis [21,22], however, it has only a
minor role in virulence [23]. PfSUB1 and TgSUB2 appear to be
critical for parasite survival [24,25]. The presence of the I2-like
insertions in these proteins suggests that the mechanism of exosite
loop-mediated proteolysis used by the D. nodosus secreted proteases
may represent a mechanism of substrate recognition that is utilized
by other bacterial proteases. Studies investigating the structure of
these proteins along with the function of their I2-like insertions will
shed some light on this hypothesis and may lead to the
development of improved diagnostic reagents and the identifica-
tion of novel vaccine and drug targets.
Materials and Methods
Construction and characterization of D. nodosus mutants
and complemented strains
Strains and plasmids are detailed in Table 3. D. nodosus strains
were routinely grown in an anaerobic chamber (Coy Laboratory
Products Inc.) as described previously [6].
To construct the single mutants, suicide plasmids were inserted
into D. nodosus strain VCS1703A by natural transformation [6].
The aprV2 and bprV mutants were complemented by transforming
the mutants with the relevant plasmids, which reconstituted the
disrupted gene and inserted a different resistance marker. The
aprV5 mutant was complemented by inserting an intact copy of
aprV5 and a kanamycin resistance marker into one of the three rrnA
operons. The aprV2bprV double mutant was constructed by
inserting the bprV suicide plasmid into an aprV2 mutant, and the
aprV2aprV5 double mutant constructed by inserting the aprV2
suicide plasmid into an aprV5 mutant. An aprV5bprV double
mutant was constructed by inserting a suicide plasmid into the
wild-type strain, which disrupted both genes when a double
crossover event occurred. Finally, a triple aprV2aprV5bprV mutant
was constructed by inserting the aprV5bprV suicide plasmid into the
aprV2 mutant.
All mutants and complemented strains were confirmed by PCR
and Southern hybridizations. PCR-RFLP analysis of the omp gene
family was used to confirm that mutants were derived from the
wild-type strain [26]. Elastase activity and protease thermostability
assays for the differentiation of benign and virulent strains of D.
nodosus were as described previously [14,16,27].
Virulence testing in sheep
Virulence testing in sheep was performed as before [6,7]. The
sheep were randomly allocated into nine groups of eight sheep and
challenged blind with the various strains. A plain agar challenge
was used as the negative control. The feet of all animals were
examined and scored for footrot lesions at the start of the trial and
then at weekly intervals using a standard lesion scoring method
[28,29]. The total weighted foot score (TWFS) was used to provide
an unambiguous overall footrot score for each animal [29]. The
trial was carried out in a PC2 containment facility at Elizabeth
Macarthur Agricultural Institute in accordance with the guidelines
of the Australian Government Office of the Gene Technology
Regulator and the Elizabeth Macarthur Agricultural Institute
Animal Ethics Committee.
Measurement of protease activity
All assays were performed in 20 mM Tris-HCl pH 8 and 5 mM
CaCl2 (buffer A) with the exception of the Elastin-Congo Red
elastase assay, which was performed in 25 mM Bis-Tris pH6.5,
150 mM NaCl, 5 mM CaCl2 and 5% glycerol. Quantitative
determination of total protease activity or elastase activity was
carried out using azocasein [26] or Elastin-Congo Red [30] assays,
respectively. Degradation of AAPVn by recombinant protease
(1 mM) was measured at 25uC as described [31]. KM and Vmax
were determined by plotting initial velocities against AAPVn
Novel Exosite Loop in Subtilisin Protease
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Plasmids Genetic Characteristics Properties Source or Reference
Strains
E. coli
DH5a F
2endA1 hsdR17(rk
2mk)thi-1l
2recA1 gyrA96relA1 rhoA
supE44 deoRF80dlacZDM15D(lacZYA argF)U169
Invitrogen
RosettaGami(DE3). pLysS D(ara-leu)7697 DlacX74 DphoA PvuII phoR araD139 ahpC
galE galK rpsL (DE3) F’[lac+ lacIq pro] gor522::Tn10 trxB
pLysSRARE (CamR, StrR, TetR)
Novagen
D. nodosus Protease produced
VCS1703A D. nodosus serogroup G wild-type, virulent AprV2, AprV5, BprV J. Egerton, University of Sydney
CS101 D. nodosus serogroup G wild-type, benign AprB2, AprB5, BprB D. Stewart, CSIRO Livestock
Industries
JIR3740*, JIR3743* VCS1703AaprV2Vtet(M) AprV5, BprV Double crossover from pJIR2097
JIR3756*, JIR3757* VCS1703AaprV5Vbla AprV2, BprV Double crossover from pJIR2309
JIR3766*, JIR3767* JIR3740bprVVerm(B) AprV5 Double crossover from pJIR2275
JIR3768*, JIR3769* JIR3757aprV2Vbla BprV Double crossover from pJIR2097
JIR3883 JIR3756rrnAVaprV5
+ AprV2, AprV5, BprV Double crossover from pJIR2545
JIR3900 JIR3743Derm(B)VaprV2
+tet(M) AprV2, AprV5, BprV Double crossover from pJIR3044
JIR3903*, JIR3905* JIR3743DaprV5bprVVerm(B) None Double crossover from pJIR3060
JIR3907*, JIR3908* VCS1703ADaprV5bprVVerm(B) AprV2 Double crossover from pJIR3060
JIR3923 JIR3743Derm(B)VaprB2
+tet(M) AprB2, AprV5, BprV Double crossover from pJIR3268
JIR3928 VCS1703AbprVVerm(B) AprV2, AprV5 Double crossover from pJIR3159
JIR3930 JIR3928Derm(B)VbprV
+Kan
R AprV2, AprV5, BprV Double crossover from pJIR3148
Plasmids Properties
pUC18 Ap
rlacZ cloning vector [54]
pWSK29 Ap
rlacZ low copy number cloning vector [55]
pWKS30 Ap
rlacZ low copy number cloning vector [55]
pWSK129 Km
rlacZ low copy number cloning vector [55]
pET22b Ap
r lacI cloning vector harbouring T7 promoter and
terminator with pBR322 and f1 origin.
Novagen
pJIR2097 pWSK29 harbouring 5.2 kb fragment containing aprV2 V tetM aprV2 suicide plasmid Recombinant
pJIR2275 pUC18 harbouring 3.4 kb fragment containing bprV V erm (B) bprV suicide plasmid Recombinant
pJIR2309 pWSK129 harbouring 3.5 kb fragment containing aprV5V bla aprV5suicide plasmid Recombinant
pJIR2545 pWKS30 harbouring 4.8 kb fragment containing D. nodosus
rrnA promoter, kanamycin resistance, aprV5, rrnA terminator
aprV5 complementation
plasmid
Recombinant
pJIR3044 pWSK29 harbouring 5.9 kb fragment containing aprV2, erm(B)
and 2.3 kb chromosomal region downstream of aprV2
aprV2 complementation
plasmid
Recombinant
pJIR3060 pWSK29 harbouring 3.75 kb fragment containing
59fragment of aprV5, erm(B) and 39fragment of bprV
aprV5/bprV suicide
plasmid
Recombinant
pJIR3148 pWSK29 harbouring 4.3 kb fragment containing
39 fragment of aprV5, kanamycin resistance, bprV
bprV complementation
plasmid
Recombinant
pJIR3159 pWSK29 harbouring 3.5 kb fragment containing bprV V erm(B) bprV suicide plasmid Recombinant
pJIR3268 pWSK29 harbouring a 5.9 kb fragment containing aprB2,
erm(B) and 2.3 kb chromosomal region downstream of aprV2
aprB2 complementation
plasmid
Recombinant
pET22b-AprV2 pET22b harbouring 1.4 kb fragment encoding 1–474
residues of the AprV2 precursor.
AprV2 expression Recombinant
pET22b-AprB2 pET22b harbouring 1.4 kb fragment encoding 1–474
residues of the AprB2 precursor.
AprB2 expression Recombinant
pET22b-AprV2.Y92F pET22b harbouring 1.4 kb fragment encoding 1–474
residues of the AprV2 precursor with a Y92F substitution.
AprV2.Y92F expression Recombinant
pET22b-AprV2.Y92D pET22b harbouring 1.4 kb fragment encoding 1–474
residues of the AprV2 precursor with a Y92D substitution.
AprV2.Y92D expression Recombinant
pET22b-AprV2.Y92L pET22b harbouring 1.4 kb fragment encoding 1–474
residues of the AprV2 precursor with a Y92L substitution.
AprV2.Y92L expression Recombinant
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Fibronectin degradation was measured by incubating human
fibronectin (1 mM, BD Biosciences) with recombinant protease
(0.1 mM) at 25uC. Cleavage products were visualised by SDS-
PAGE. Proteolytic degradation of hoof was determined by
incubating dissected hoof material (2.2% (w/v) in buffer A) from
a disease-free sheep with recombinant protease (110 mg/ml) at
25uC. Samples were taken over a 16 hour period and degradation
products were visualised by SDS-PAGE.
Proteolytic digestion of hoof and substrate identification
by in-gel tryptic digestion and LCMS
Hoof material (14% (w/v) in buffer A) from a disease-free sheep
was incubated with 100 mg of recombinant protease at 25uC for
18 h. Degradation products were separated by SDS-PAGE. The
bands were excised and subjected to in-gel tryptic digestion and
the digests analysed by LC-MS/MS using a HCT ULTRA ion
trap mass spectrometer (BrukerDaltonics) coupled online with a
1200 series capillary HPLC (Agilent technologies). Proteins were
identified by searching the LC-MS/MS data against the National
Center for Biotechnology Information (NCBI) non-redundant and
Swiss-Prot databases using the MASCOT search engine (version
2.1, Matrix Science Inc.) with all taxonomy selected.
Protein production, crystallisation and data collection
AprV2 and AprB2 were purified and crystallised as before [32].
Data collection statistics have been reported [32]. The expression
construct for AprV2.C141S was generated using the Quikchange
site-directed mutagenesis kit (Stratagene) and pET22b.AprV2 as
the template. Expression, purification and crystallisation of
AprV2.C141S were as for AprV2. Data collection statistics for
AprV2.C141S are in Table S1.
Structure determination and refinement
Unless stated otherwise, all programs used for structural and
crystallographic analysis were located within the CCP4 interface
[33] to the CCP4 suite [34]. Manual building and maximum
likelihood refinement were carried out using COOT [35] and
REFMAC5 [36], respectively. The protease structures were solved
by molecular replacement using PHASER [37]. A search model
for AprB2 was derived from the coordinates of Bacillus Ak.1
protease (PDB code 1DBI [38]), identified using the FFAS server
[39]. The search model was generated using the SCRWL server
and consisted of all conserved side-chains with the remaining non-
alanine/glycine residues truncated at the C
c atom [40]. The initial
model of AprB2 was subject to several iterations of manual
building and refinement. The model was then subjected to
automatic building using ARP/wARP [41] before the structure
was completed by more cycles of manual building and refinement.
The refined AprB2 structure with the I2 loop deleted was used as
the MR search model for AprV2 and AprV2.C141S. The initial
models were subjected to simulated annealing using PHENIX
[42,43]. Successive rounds of manual building and refinement
incorporating TLS [44] generated the final models. Water
molecules were added to all models using ARP/warp v 5.0
[45,46]. Structure validation was carried out using MolProbity
[47] and COOT [35]. Refinement statistics for the structures
determined are presented in Table 2. The coordinates and
structure factors are available from the Protein Data Bank (2LPA;
2LPC; 2LPC). Raw data and images are available from TARDIS
(www.tardis.edu.au) [48].
Fluorescence quenching experiments
Recombinant protease (0.5 mM in buffer A) was incubated with
increasing amounts of quenching solution (2 M KI and 1 mM
Na2S2O3) and the change in the fluorescence emission intensity of
the tryptophan residues (lex290 nm/lem340 nm) was measured
using a Perkin-Elmer LS50B spectrofluorometer. The data were
analysed as before [49].
Ethics statement
The sheep virulence experiments were carried out in a PC2
containment facility at the Elizabeth Macarthur Agricultural
Institute in accordance with the guidelines of the Australian
Government Office of the Gene Technology Regulator and the
Elizabeth Macarthur Agricultural Institute Animal Ethics Com-
mittee. These experiments were approved by the Elizabeth
Macarthur Agricultural Institute Animal Ethics Committee.
Supporting Information
Figure S1 Characterisation of the D. nodosus wild-type and
protease mutants. (A) Elastase activity of protease mutants and the
complemented strains. Elastase activity was determined by
growing the strains indicated on TAS agar containing 0.3%
elastin for 28 days. A zone of clearing of the insoluble elastin
around the growth streak indicates elastase activity. (B) Protease
thermostability of protease mutants and complemented strains.
Culture supernatants were diluted 1:5 in Hepes Buffer (5.6 mM
Hepes acid, 113.6 mM Hepes sodium salt, 10 mM CaCl2,
0.1 mM Zwittergent 3–14, pH 8.5 at 40uC) and 20 ml aliquots
placed into wells in a gelatin-agarose gel after heating at 67uC for
0, 8 and 16 min [16]. Gels were then incubated at 37uC in a moist
chamber overnight and then immersed in hot saturated ammo-
nium sulphate to precipitate undigested protein. Zones of clearing
around wells indicate protease activity.
Found at: doi:10.1371/journal.ppat.1001210.s001 (5.02 MB TIF)
Figure S2 Calcium binding sites in AprV2. Stereo diagrams
showing the calcium binding sites in AprV2. Calcium ions are
indicated as blue spheres, water molecules are indicated as red
spheres. (A) The Ca-I binding site. This site corresponds to the
high affinity A-site in the archetypal subtilisin BPN9 [56]. The
Plasmids Genetic Characteristics Properties Source or Reference
pET22b-AprV2.Y92A pET22b harbouring 1.4 kb fragment encoding 1–474
residues of the AprV2 precursor with a Y92A substitution.
AprV2.Y92A expression Recombinant
pET22b-AprV2.C141S pET22b harbouring 1.4 kb fragment encoding 1–474 residues
of the AprV2 precursor with a C141S substitution.
AprV2.C141S expression Recombinant
*Independently derived mutants.
doi:10.1371/journal.ppat.1001210.t003
Table 3. Cont.
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+ ion is coordinated to the side chain oxygen atoms of Asp5
(O
d1), Asp49 (O
d1 and O
d2) and Asn119 (O
d1) and the carbonyl
oxygen atoms from Val116, Ile121 and Val123. (B) The Ca-II
binding site. The Ca2
+ ion coordinates to four side chain oxygen
atoms from Asp69 (O
d1 and O
d2), Asp71 (O
d1) and Asp74 (O
d1),
two main chain carbonyl oxygen atoms from Asp71 and Gly72
and a water molecule. This site is unique to AprV2 and AprB2.
(C) The Ca-III binding site. The Ca2
+ ion is more solvent exposed
than the other bound Ca ions and coordinates to the side chain
oxygen atoms of Asp59 (O
d2), Asp69 (O
d2) and Asp74 (O
d1 and
O
d2) along with the carbonyl oxygen atom of Asp76 and two water
molecules. All calcium ions form a distorted pentagonal,
bipyrimidal coordination geometry. The figure was prepared
using PyMol [51].
Found at: doi:10.1371/journal.ppat.1001210.s002 (1.47 MB TIF)
Figure S3 The I2 loop. (A) AprV2 contains a novel disulfide
tethered extended loop. Structure based sequence alignment of
AkP (1DBI), thermitase (TM, 1THM), Carlsburg subtilisin (CBG,
1AF4), BPN9 (1SUP) and savinase (SAV, 1SVN) with AprV2 and
AprB2. Secondary structure elements present in AprV2 are shown
above the alignment. Residue numbering is for AprV2. The filled
arrows indicate active site residues. The open arrow indicates the
oxyanion hole. The I1, I2, I3 and I4 loops are labeled. Residues
highlighted in red indicate strictly conserved residues. Residues in
red text indicate those with similar physiochemical properties. The
alignment was generated using the program MUSTANG [52] and
ESPript [57]. Secondary structure elements were calculated using
stride [53]. (B) Subtilisin-like proteases from pathogens that
contain an I2-like insertion. Sequence alignment of AprV2 (D.
nodosus), MprA (B. pseudomallei), PfSUB1 (P. falciparum), TgSUB1 (T.
gondii), TgSUB2 (T. gondii), XC (X. campestris), PP (P. piscicida) and
BPN9 (B. amyloliquefaciens). Secondary structure elements present in
AprV2 are shown above the alignment. Residue numbering is for
AprV2. Residues highlighted in red indicate strictly conserved
residues. Residues written in red indicate those with similar
physiochemical properties. The alignment was generated using the
program Clustal W [58] and ESPript [57]. Secondary structure
elements were calculated using stride [53].
Found at: doi:10.1371/journal.ppat.1001210.s003 (1.42 MB TIF)
Figure S4 Degradation of fibronectin by AprV2 and mutants.
Purified protease was incubated with fibronectin at 25uC. The
degradation of fibronectin over time was monitored by SDS-
PAGE analysis. Intact fibronectin (FN) is .250 kDa. Degradation
products are observed at molecular weight ,250 kDa.
Found at: doi:10.1371/journal.ppat.1001210.s004 (5.02 MB TIF)
Figure S5 Degradation of sheep hoof by AprV2 and mutants.
Purified protease was incubated with hoof material from a disease
free sheep at 25uC. The degradation over time was monitored by
SDS-PAGE analysis. Degradation products were observed be-
tween 5–15 kDa. RP: recombinant protease; HDP: hoof degra-
dation products.
Found at: doi:10.1371/journal.ppat.1001210.s005 (5.95 MB TIF)
Figure S6 AprV2.C141S is structurally similar to AprV2. The
crystal structure of AprV2.C141S and AprV2 were superimposed
using LSQKAB in CCP4 [33,34]. The Ca RMSD for each residue
is plotted. The secondary structure of each residue is indicated
with a-helices shown in dark grey and b-strands shown in black.
The loop insertions are shown in grey and labelled. The location
of the catalytic triad (Asp41, His105 and Ser277) and the disrupted
disulphide bond (Cys89 and Cys141) is labelled. Secondary
structure elements were calculated using stride [53].
Found at: doi:10.1371/journal.ppat.1001210.s006 (2.89 MB TIF)
Table S1 Data collection statistics for AprV2.C141S.
Found at: doi:10.1371/journal.ppat.1001210.s007 (0.05 MB
DOC)
Acknowledgments
We thank Craig Kristo of the Faculty of Veterinary Science, University of
Sydney, and the technical staff of the Elizabeth Macarthur Agricultural
Institute, for invaluable assistance with the sheep virulence trials. We thank
the Monash University protein production unit for purification of the
recombinant proteases and Dr John Price of the Department of
Biochemistry and Molecular Biology, Monash University, who provided
purified fibronectin.
Author Contributions
Conceived and designed the experiments: RMK WW OPD XH DW DP
CJR RHPL SM SBR VL GAP RNP SPB AIS IM RJW JCW CJP JIR.
Performed the experiments: RMK WW OPD XH DW DP CJR RHPL
SM SBR VL GAP IM RJW CJP. Analyzed the data: RMK WW OPD XH
DW DP CJR RHPL SM SBR VL GAP RNP SPB AIS IM RJW JCW CJP
JIR. Wrote the paper: RMK WW OPD RJW JCW CJP JIR.
References
1. Stewart DJ (1989) Footrot of sheep. In: Egerton JR, Yong WK, Riffkin GG, eds.
Footrot and foot abscess of ruminants. Boca Raton: CRC Press. pp 5–45.
2. Green LE, George TR (2008) Assessment of current knowledge of footrot in
sheep with particular reference to Dichelobacter nodosus and implications for
elimination or control strategies for sheep in Great Britain. Vet J 175: 173–
180.
3. Wani SA, Samanta I (2006) Current understanding of the aetiology and
laboratory diagnosis of footrot. Vet J 171: 421–428.
4. Egerton JR, Roberts DS, Parsonson IM (1969) The aetiology and pathogenesis
of ovine footrot. I. A histological study of the bacterial invasion. J Comp Pathol
81: 179–185.
5. Stewart DJ, Clark BL, Jarret RG (1984) Differences between strains of Bacteroides
nodosus in their effects on the severity of footrot, bodyweight and wool growth on
Merino sheep. Aust Vet J 61: 349–352.
6. Kennan RM, Dhungyel OP, Whittington RJ, Egerton JR, Rood JI (2001) The
type IV fimbrial subunit gene (fimA)o fDichelobacter nodosus is essential for
virulence, protease secretion, and natural competence. J Bacteriol 183:
4451–4458.
7. Han X, Kennan RM, Davies JK, Reddacliff LA, Dhungyel OP, et al. (2008)
Twitching motility is essential for virulence in Dichelobacter nodosus. J Bacteriol
190: 3323–3335.
8. Kortt AA, Riffkin MC, Focareta A, Stewart DJ (1993) Amino acid sequence of
extracellular acidic protease V5 of Dichelobacter nodosus, the causative organism of
ovine footrot. Biochem Mol Biol Int 29: 989–998.
9. Billington SJ, Johnston JL, Rood JI (1996) Virulence regions and virulence
factors of the ovine footrot pathogen, Dichelobacter nodosus. FEMS Microbiol Lett
145: 147–156.
10. Lilley GG, Stewart DJ, Kortt AA (1992) Amino acid and DNA
sequences of an extracellular basic protease of Dichelobacter nodosus show
that it is a member of the subtilisin family of proteases. Eur J Biochem 210:
13–21.
11. Riffkin MC, Focareta A, Edwards RD, Stewart DJ, Kortt AA (1993) Cloning,
sequence and expression of the gene (aprV5) encoding extracellular serine acidic
protease V5 from Dichelobacter nodosus. Gene 137: 259–264.
12. Riffkin MC, Wang LF, Kortt AA, Stewart DJ (1995) A single amino-acid change
between the antigenically different extracellular serine proteases V2 and B2 from
Dichelobacter nodosus. Gene 167: 279–283.
13. Siezen RJ, Leunissen JA (1997) Subtilases: the superfamily of subtilisin-like serine
proteases. Protein Sci 6: 501–523.
14. Stewart DJ (1979) The role of elastase in the differentiation of Bacteroides nodosus
infections in sheep and cattle. Res Vet Sci 27: 99–105.
15. Depiazzi LJ, Henderson J, Penhale WJ (1990) Measurement of protease
thermostability, twitching motility and colony size of Bacteroides nodosus.V e t
Microbiol 22: 353–363.
16. Palmer MA (1993) A gelatin test to detect activity and stability of proteases
produced by Dichelobacter nodosus. Vet Microbiol 36: 113–122.
17. Lilley GG, Riffkin MC, Stewart DJ, Kortt AA (1995) Nucleotide and deduced
protein sequence of the extracellular, serine basic protease gene (bprB) from
Novel Exosite Loop in Subtilisin Protease
PLoS Pathogens | www.plospathogens.org 11 November 2010 | Volume 6 | Issue 11 | e1001210Dichelobacter nodosus strain 305: comparison with the basic protease gene (bprV)
from virulent strain 198. Biochem Mol Biol Int 36: 101–111.
18. Kortt AA, Stewart DJ (1994) Properties of the extracellular acidic proteases of
Dichelobacter nodosus. Stability and specificity of peptide bond cleavage. Biochem
Mol Biol Int 34: 1167–1176.
19. Depiazzi LJ, Richards RB (1979) A degrading proteinase test to distinguish
benign and virulent ovine isolates of Bacteroides nodosus. Aust Vet J 55: 25–28.
20. Liu D, Yong WK (1993) Use of elastase test, gelatin gel test and electrophoretic
zymogram to determine virulence of Dichelobacter nodosus isolated from ovine foot
rot. Res Vet Sci 55: 124–129.
21. Lee MA, Liu Y (2000) Sequencing and characterization of a novel serine
metalloprotease from Burkholderia pseudomallei. FEMS Microbiol Lett 192: 67–72.
22. Chin C-Y, Othman R, Nathan S (2007) The Burkholderia pseudomallei serine
protease MprA is autoproteolytically activated to produce a highly stable
enzyme. Enzyme Microb Technol 40: 370–377.
23. Valade E, Thibault FM, Gauthier YP, Palencia M, Popoff MY, et al. (2004) The
PmlI-PmlR quorum-sensing system in Burkholderia pseudomallei plays a key role in
virulence and modulates production of the MprA protease. J Bacteriol 186:
2288–2294.
24. Yeoh S, O’Donnell RA, Koussis K, Dluzewski AR, Ansell KH, et al. (2007)
Subcellular discharge of a serine protease mediates release of invasive malaria
parasites from host erythrocytes. Cell 131: 1072–1083.
25. Miller SA, Thathy V, Ajioka JW, Blackman MJ, Kim K (2003) TgSUB2 is a
Toxoplasma gondii rhoptry organelle processing proteinase. Mol Microbiol 49:
883–894.
26. Kennan RM, Dhungyel OP, Whittington RJ, Egerton JR, Rood JI (2003)
Transformation-mediated serogroup conversion of Dichelobacter nodosus.V e t
Microbiol 92: 169–178.
27. Kortt AA, Burns JE, Stewart DJ (1983) Detection of the extracellular proteases
of Bacteroides nodosus in polyacrylamide gels: a rapid method of distinguishing
virulent and benign ovine isolates. Res Vet Sci 35: 171–174.
28. Egerton JR, Roberts DS (1971) Vaccination against ovine foot-rot. J Comp
Pathol 81: 179–185.
29. Whittington RJ, Nicholls PJ (1995) Grading the lesions of ovine footrot. Res Vet
Sci 58: 26–34.
30. Ohman DE, Cryz SJ, Iglewski BH (1980) Isolation and characterization of
Pseudomonas aeruginosa PAO mutant that produces altered elastase. J Bacteriol
142: 836–842.
31. Betsuyaku T, Nishimura M, Yoshioka A, Takeyabu K, Miyamoto K, et al.
(1996) Elastin-derived peptides and neutrophil elastase in bronchoalveolar
lavage fluid. Am J Respir Crit Care Med 154: 720–724.
32. Wong W, Kennan R, Rosaldo CJ, Rood JI, Whisstock J, et al. (2010)
Crystallization of the virulent and benign subtilisin-like proteases from the ovine
foot-rot pathogen, Dichelobacter nodosus. Acta Crystallogr F 66: 289–293.
33. Potterton E, Briggs P, Turkenburg M, Dodson E (2003) A graphical user
interface to the CCP4 program suite. Acta Crystallogr D Biol Crystallogr 59:
1131–1137.
34. Collaborative Computational Project N (1994) The CCP4 suite: programs for
protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760–763.
35. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics.
Acta Crystallogr D Biol Crystallogr 60: 2126–2132.
36. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular
structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystal-
logr 53: 240–255.
37. McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ (2005) Likelihood-
enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr 61:
458–464.
38. Smith CA, Toogood HS, Baker HM, Daniel RM, Baker EN (1999) Calcium-
mediated thermostability in the subtilisin superfamily: the crystal structure of
Bacillus Ak.1 protease at 1.8 A resolution. J Mol Biol 294: 1027–1040.
39. Jaroszewski L, Rychlewski L, Li Z, Li W, Godzik A (2005) FFAS03: a server for
profile--profile sequence alignments. Nucleic Acids Res 33: W284–288.
40. Canutescu AA, Shelenkov AA, Dunbrack RL, Jr. (2003) A graph-theory
algorithm for rapid protein side-chain prediction. Protein Sci 12: 2001–2014.
41. Langer G, Cohen SX, Lamzin VS, Perrakis A (2008) Automated macromolec-
ular model building for X-ray crystallography using ARP/wARP version 7. Nat
Protoc 3: 1171–1179.
42. Afonine PV, Grosse-Kunstleve, Adams RW (2005) The Phenix refinement
framework. CCP4 Newsletter 42: Contribution 8.
43. Brunger AT, Kuriyan J, Karplus M (1987) Crystallographic R Factor
Refinement by Molecular Dynamics. Science 235: 458–460.
44. Painter J, Merritt EA (2006) Optimal description of a protein structure in terms
of multiple groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr
62: 439–450.
45. Perrakis A, Sixma TK, Wilson KS, Lamzin VS (1997) wARP: improvement and
extension of crystallographic phases by weighted averaging of multiple-refined
dummy atomic models. Acta Crystallogr D Biol Crystallogr 53: 448–455.
46. Lamzin VS, Wilson KS (1993) Automated refinement of protein models. Acta
Crystallogr D Biol Crystallogr 49: 129–147.
47. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, et al. (2007)
MolProbity: all-atom contacts and structure validation for proteins and nucleic
acids. Nucleic Acids Res 35: W375–383.
48. Androulakis S, Schmidberger J, Bate MA, DeGori R, Beitz A, et al. (2008)
Federated repositories of X-ray diffraction images. Acta Crystallogr D Biol
Crystallogr D64: 810–814.
49. Lehrer SS (1971) Solute perturbation of protein fluorescence. The quenching of
the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion.
Biochemistry 10: 3254–3263.
50. Potterton L, McNicholas S, Krissinel E, Gruber J, Cowtan K, et al. (2004)
Developments in the CCP4 molecular-graphics project. Acta Crystallogr D Biol
Crystallogr 60: 2288–2294.
51. DeLano WL (2002) The PyMOL User’s Manual Scientific D, editor. San
Carlos, CA, USA.
52. Konagurthu AS, Whisstock JC, Stuckey PJ, Lesk AMPS (2006) MUSTANG: A
multiple structural alignment algorithim. Proteins: Structure, Function and
Bioinformatics 64: 559–574.
53. Frishman D, Argos P (1995) Knowledge-based protein secondary structure
assignment. Proteins 23: 566–579.
54. Vieira J, Messing J (1982) The pUC plasmids, an M13mp7-derived system for
insertion mutagenesis and sequencing with synthetic universal primers. Gene 19:
259–268.
55. Wang RF, Kushner SR (1991) Construction of versatile low-copy-number
vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 100:
195–199.
56. Gallagher T, Oliver J, Bott R, Betzel C, Gilliland GL (1996) Subtilisin BPN’ at
1.6 A resolution: analysis for discrete disorder and comparison of crystal forms.
Acta Crystallogr 52: 1125–1135.
57. Gouet P, Courcelle E, Stuart DI, Metoz F (1999) ESPript: analysis of multiple
sequence alignments in PostScript. Bioinformatics 15: 305–308.
58. Thompson JD, Higgins DG, Gibson TJ (1994) Clustal W: improving the
sensitivity of progressive multiple sequence alignments through sequence
weighing, positions-specific gap penalties and weight matrix choice. Nucleic
Acids Res 22: 4673–4680.
Novel Exosite Loop in Subtilisin Protease
PLoS Pathogens | www.plospathogens.org 12 November 2010 | Volume 6 | Issue 11 | e1001210